{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:14:06Z","timestamp":1792120446992,"version":"4.4.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021\u201302189 and 2024-03161"],"award-info":[{"award-number":["2021\u201302189 and 2024-03161"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021\u201302814"],"award-info":[{"award-number":["2021\u201302814"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","award":["2020\u201301267 and 2023-00905"],"award-info":[{"award-number":["2020\u201301267 and 2023-00905"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NEURO Sweden, Region Uppsala (ALF-grant and R&D funds), and \u00c5ke Wiberg"},{"DOI":"10.13039\/100018367","name":"The Swedish Foundation for MS Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006636","name":"Forte","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Marianne and Marcus Wallenberg Foundation, Region Uppsala"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Exposure to per- and polyfluorinated substances (PFAS) and hydroxylated polychlorinated biphenyls (OH-PCBs) is associated with adverse human health effects, including immunosuppression. It is unknown if these substances can affect the course of autoimmune diseases. This study was based on 907 individuals with multiple sclerosis (MS) and 907 matched controls, where the MS cases were followed longitudinally using the Swedish MS register. We demonstrate sex- and disease-specific differences in serum PFAS concentrations between individuals with MS and controls. Moreover, two OH-PCBs (4-OH-CB187 and 3-OH-CB153) are associated with an increased risk of developing multiple sclerosis, regardless of sex and immigration status. With a clinical follow-up time of up to 18 years, an increase in serum concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorodecanoic acid (PFDA) decreases the risk of confirmed disability worsening in both sexes, as well as perfluoroheptanesulfonic acid (PFHpS) and perfluorononanoic acid (PFNA), only in males with MS. These results show previously unknown associations between OH-PCBs and the risk of developing MS, as well as the inverse associations between PFAS exposure and the risk of disability worsening in MS.<\/jats:p>","DOI":"10.1038\/s41467-025-57172-3","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:44:34Z","timestamp":1740728674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening"],"prefix":"10.1038","volume":"16","author":[{"given":"Aina","family":"Vaivade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-9525","authenticated-orcid":false,"given":"Ida","family":"Erngren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0226-1047","authenticated-orcid":false,"given":"Eva","family":"Freyhult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Emami Khoonsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-7546","authenticated-orcid":false,"given":"Yassine","family":"Noui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Al-Grety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"\u00c5kerfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-2864","authenticated-orcid":false,"given":"Ola","family":"Spjuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Olof","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-4726","authenticated-orcid":false,"given":"Ingrid","family":"Kockum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-4749","authenticated-orcid":false,"given":"Anna Karin","family":"Hedstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1688-6697","authenticated-orcid":false,"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7045-1806","authenticated-orcid":false,"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-1410","authenticated-orcid":false,"given":"Kim","family":"Kultima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"57172_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson, R. & Giovannoni, G. Multiple sclerosis - a review. Eur. J. Neurol. 26, 27\u201340 (2019).","journal-title":"Eur. J. Neurol."},{"key":"57172_CR2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield, K. E., Jensen, L. T., Kaufmann, M., Friese, M. A. & Fugger, L. The immunology of multiple sclerosis. Nat. Rev. Immunol. 22, 734\u2013750 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"57172_CR3","unstructured":"Multiple Sclerosis International Federation \u2013 Atlas of MS \u2013 3rd Edition. Number of people with MS. https:\/\/www.atlasofms.org\/map\/global\/epidemiology\/number-ofpeople-with-ms. (2024)."},{"key":"57172_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley, M. P., Goldschmidt, C. H. & Rae-Grant, A. D. Diagnosis and treatment of multiple sclerosis: a review. JAMA 325, 765\u2013779 (2021).","journal-title":"JAMA"},{"key":"57172_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich, D. S., Lucchinetti, C. F. & Calabresi, P. A. Multiple sclerosis. N. Engl. J. Med. 378, 169\u2013180 (2018).","journal-title":"N. Engl. J. Med."},{"key":"57172_CR6","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365, eaav7188 (2019)."},{"key":"57172_CR7","doi-asserted-by":"crossref","unstructured":"Ascherio, A., Munger, K. L. & Simon, K. C. Vitamin D and multiple sclerosis. Lancet Neurol. 9, 783 (2010).","DOI":"10.1016\/S1474-4422(10)70086-7"},{"key":"57172_CR8","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S. & Ascherio, A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296, 2832\u20132838 (2006).","journal-title":"JAMA"},{"key":"57172_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/1352458515594040","volume":"22","author":"I van der Mei","year":"2016","unstructured":"van der Mei, I. et al. Population attributable fractions and joint effects of key risk factors for multiple sclerosis. Mult. Scler. 22, 461\u2013469 (2016).","journal-title":"Mult. Scler."},{"key":"57172_CR10","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","volume":"6","author":"E Waubant","year":"2019","unstructured":"Waubant, E. et al. Environmental and genetic risk factors for MS: an integrated review. Ann. Clin. Transl. Neurol. 6, 1905\u20131922 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"57172_CR11","first-page":"988","volume":"28","author":"M Ward","year":"2022","unstructured":"Ward, M. & Goldman, M. D. Epidemiology and pathophysiology of multiple sclerosis. Continuum 28, 988\u20131005 (2022).","journal-title":"Continuum"},{"key":"57172_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/oemed-2017-104651","volume":"75","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup. Environ. Med. 75, 46\u201351 (2018).","journal-title":"Occup. Environ. Med."},{"key":"57172_CR13","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1039\/D0EM00291G","volume":"22","author":"J Gl\u00fcge","year":"2020","unstructured":"Gl\u00fcge, J. et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ. Sci. Process. Impacts 22, 2345\u20132373 (2020).","journal-title":"Environ. Sci. Process. Impacts"},{"key":"57172_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-022-00958-5","volume":"22","author":"V Ehrlich","year":"2023","unstructured":"Ehrlich, V. et al. Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS). Environ. Health 22, 19 (2023).","journal-title":"Environ. Health"},{"key":"57172_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/10408449409049308","volume":"24","author":"SH Safe","year":"1994","unstructured":"Safe, S. H. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit. Rev. Toxicol. 24, 87\u2013149 (1994).","journal-title":"Crit. Rev. Toxicol."},{"key":"57172_CR16","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1007\/s11356-013-1742-6","volume":"21","author":"R Tehrani","year":"2014","unstructured":"Tehrani, R. & Van Aken, B. Hydroxylated polychlorinated biphenyls in the environment: sources, fate, and toxicities. Environ. Sci. Pollut. Res. Int. 21, 6334\u20136345 (2014).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"57172_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105018118","volume":"118","author":"C Beans","year":"2021","unstructured":"Beans, C. How \u2018forever chemicals\u2019 might impair the immune system. Proc. Natl Acad. Sci. USA 118, e2105018118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57172_CR18","doi-asserted-by":"publisher","first-page":"107734","DOI":"10.1016\/j.envint.2023.107734","volume":"172","author":"L Crawford","year":"2023","unstructured":"Crawford, L. et al. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances. Environ. Int. 172, 107734 (2023).","journal-title":"Environ. Int."},{"key":"57172_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.envres.2018.08.004","volume":"171","author":"B Pachkowski","year":"2019","unstructured":"Pachkowski, B., Post, G. B. & Stern, A. H. The derivation of a reference dose (RfD) for perfluorooctane sulfonate (PFOS) based on immune suppression. Environ. Res. 171, 452\u2013469 (2019).","journal-title":"Environ. Res."},{"key":"57172_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e08160","volume":"7","author":"H von Holst","year":"2021","unstructured":"von Holst, H. et al. Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies. Heliyon 7, e08160 (2021).","journal-title":"Heliyon"},{"key":"57172_CR21","doi-asserted-by":"publisher","first-page":"106395","DOI":"10.1016\/j.envint.2021.106395","volume":"149","author":"L Dalsager","year":"2021","unstructured":"Dalsager, L. et al. Exposure to perfluoroalkyl substances during fetal life and hospitalization for infectious disease in childhood: a study among 1,503 children from the Odense Child Cohort. Environ. Int. 149, 106395 (2021).","journal-title":"Environ. Int."},{"key":"57172_CR22","unstructured":"Toxicological Profile for Perfluoroalkyls (Agency for Toxic Substances and Disease Registry, 2009)."},{"key":"57172_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3109\/1547691X.2015.1067259","volume":"13","author":"K Kielsen","year":"2016","unstructured":"Kielsen, K. et al. Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J. Immunotoxicol. 13, 270\u2013273 (2016).","journal-title":"J. Immunotoxicol."},{"key":"57172_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/1547691X.2021.1922957","volume":"18","author":"Y-H Shih","year":"2021","unstructured":"Shih, Y.-H. et al. Serum vaccine antibody concentrations in adults exposed to per- and polyfluoroalkyl substances: a birth cohort in the Faroe Islands. J. Immunotoxicol. 18, 85\u201392 (2021).","journal-title":"J. Immunotoxicol."},{"key":"57172_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.envres.2016.05.020","volume":"149","author":"CR Stein","year":"2016","unstructured":"Stein, C. R. et al. Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults. Environ. Res. 149, 171\u2013178 (2016).","journal-title":"Environ. Res."},{"key":"57172_CR26","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41370-023-00564-8","volume":"33","author":"JM Bailey","year":"2023","unstructured":"Bailey, J. M. et al. Immune response to COVID-19 vaccination in a population with a history of elevated exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water. J. Expo. Sci. Environ. Epidemiol. 33, 725\u2013736 (2023).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"57172_CR27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1289\/ehp.1206449","volume":"121","author":"K Steenland","year":"2013","unstructured":"Steenland, K., Zhao, L., Winquist, A. & Parks, C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ. Health Perspect. 121, 900\u2013905 (2013).","journal-title":"Environ. Health Perspect."},{"key":"57172_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12940-024-01073-3","volume":"23","author":"J-C Qiao","year":"2024","unstructured":"Qiao, J.-C. et al. Associations of per- and polyfluoroalkyl substances (PFAS) and their mixture with risk of rheumatoid arthritis in the U.S. adult population. Environ. Health 23, 1\u201314 (2024).","journal-title":"Environ. Health"},{"key":"57172_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jneuroim.2019.03.002","volume":"330","author":"C Ammitzb\u00f8ll","year":"2019","unstructured":"Ammitzb\u00f8ll, C. et al. Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation. J. Neuroimmunol. 330, 90\u201395 (2019).","journal-title":"J. Neuroimmunol."},{"key":"57172_CR30","doi-asserted-by":"crossref","unstructured":"Andersen, O. From the Gothenburg cohort to the Swedish multiple sclerosis registry. Acta Neurol. Scand. Suppl. 13\u201319 (2012).","DOI":"10.1111\/ane.12023"},{"key":"57172_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/10408444.2014.999365","volume":"45","author":"FA Grimm","year":"2015","unstructured":"Grimm, F. A. et al. Metabolism and metabolites of polychlorinated biphenyls. Crit. Rev. Toxicol. 45, 245\u2013272 (2015).","journal-title":"Crit. Rev. Toxicol."},{"key":"57172_CR32","doi-asserted-by":"publisher","first-page":"106333","DOI":"10.1016\/j.envint.2020.106333","volume":"147","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Serum perfluoroalkyl substances in residents following long-term drinking water contamination from firefighting foam in Ronneby, Sweden. Environ. Int. 147, 106333 (2021).","journal-title":"Environ. Int."},{"key":"57172_CR33","doi-asserted-by":"publisher","first-page":"27007","DOI":"10.1289\/EHP5337","volume":"128","author":"G Pitter","year":"2020","unstructured":"Pitter, G. et al. Serum levels of perfluoroalkyl substances (PFAS) in adolescents and young adults exposed to contaminated drinking water in the Veneto Region, Italy: a cross-sectional study based on a health surveillance program. Environ. Health Perspect. 128, 27007 (2020).","journal-title":"Environ. Health Perspect."},{"key":"57172_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.envres.2017.07.050","volume":"159","author":"J Stubleski","year":"2017","unstructured":"Stubleski, J. et al. The effect of drinking water contaminated with perfluoroalkyl substances on a 10-year longitudinal trend of plasma levels in an elderly Uppsala cohort. Environ. Res. 159, 95\u2013102 (2017).","journal-title":"Environ. Res."},{"key":"57172_CR35","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1093\/brain\/awv258","volume":"138","author":"T Kalincik","year":"2015","unstructured":"Kalincik, T. et al. Defining reliable disability outcomes in multiple sclerosis. Brain 138, 3287\u20133298 (2015).","journal-title":"Brain"},{"key":"57172_CR36","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamaneurol.2023.3331","volume":"80","author":"J M\u00fcller","year":"2023","unstructured":"M\u00fcller, J. et al. Harmonizing definitions for progression independent of relapse activity in multiple sclerosis: a systematic review. JAMA Neurol. 80, 1232\u20131245 (2023).","journal-title":"JAMA Neurol."},{"key":"57172_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.envres.2019.04.034","volume":"174","author":"RB Jain","year":"2019","unstructured":"Jain, R. B. & Ducatman, A. Perfluoroalkyl acids serum concentrations and their relationship to biomarkers of renal failure: serum and urine albumin, creatinine, and albumin creatinine ratios across the spectrum of glomerular function among US adults. Environ. Res. 174, 143\u2013151 (2019).","journal-title":"Environ. Res."},{"key":"57172_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2019.105324","volume":"137","author":"M Forsthuber","year":"2020","unstructured":"Forsthuber, M. Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma. Environ. Int. 137, 105324 (2020).","journal-title":"Environ. Int."},{"key":"57172_CR39","first-page":"526067","volume":"14","author":"S-Y Zhang","year":"2020","unstructured":"Zhang, S.-Y., Gui, L.-N., Liu, Y.-Y., Shi, S. & Cheng, Y. Oxidative stress marker aberrations in multiple sclerosis: a meta-analysis study. Front. Neurosci. 14, 526067 (2020).","journal-title":"Front. Neurosci."},{"key":"57172_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74026-8","volume":"10","author":"A Di Nisio","year":"2020","unstructured":"Di Nisio, A. et al. Endocrine disruption of vitamin D activity by perfluoro-octanoic acid (PFOA). Sci. Rep. 10, 16789 (2020).","journal-title":"Sci. Rep."},{"key":"57172_CR41","doi-asserted-by":"publisher","first-page":"114832","DOI":"10.1016\/j.envres.2022.114832","volume":"217","author":"ER Azhagiya Singam","year":"2023","unstructured":"Azhagiya Singam, E. R. et al. The vitamin D receptor as a potential target for the toxic effects of per- and polyfluoroalkyl substances (PFASs): an in-silico study. Environ. Res. 217, 114832 (2023).","journal-title":"Environ. Res."},{"key":"57172_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111713","volume":"202","author":"CJ Chang","year":"2021","unstructured":"Chang, C. J. Associations of single and multiple per- and polyfluoroalkyl substance (PFAS) exposure with vitamin D biomarkers in African American women during pregnancy. Environ. Res. 202, 111713 (2021).","journal-title":"Environ. Res."},{"key":"57172_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41370-018-0097-y","volume":"29","author":"JC DeWitt","year":"2019","unstructured":"DeWitt, J. C., Blossom, S. J. & Schaider, L. A. Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence. J. Expo. Sci. Environ. Epidemiol. 29, 148\u2013156 (2019).","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"57172_CR44","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(23)00621-9","volume":"401","author":"X Wen","year":"2023","unstructured":"Wen, X. & Li, B. A population-based study on autoimmune disease. Lancet 401, 1829\u20131831 (2023).","journal-title":"Lancet"},{"key":"57172_CR45","unstructured":"National Toxicology Program (NTP). NTP monograph on immunotoxicity associated with exposure to perfluorooctanoic acid or perfluorooctane sulfonate. https:\/\/ntp.niehs.nih.gov\/ ntp\/ohat\/pfoa_pfos\/pfoa_pfosmonograph_508.pdf (2016)."},{"key":"57172_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/10408444.2015.1122573","volume":"46","author":"ET Chang","year":"2016","unstructured":"Chang, E. T., Adami, H.-O., Boffetta, P., Wedner, H. J. & Mandel, J. S. A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans. Crit. Rev. Toxicol. 46, 279\u2013331 (2016).","journal-title":"Crit. Rev. Toxicol."},{"key":"57172_CR47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jdiacomp.2016.05.001","volume":"30","author":"B Conway","year":"2016","unstructured":"Conway, B., Innes, K. E. & Long, D. Perfluoroalkyl substances and beta cell deficient diabetes. J. Diabetes Complications 30, 993 (2016).","journal-title":"J. Diabetes Complications"},{"key":"57172_CR48","doi-asserted-by":"publisher","first-page":"115207","DOI":"10.1016\/j.envpol.2020.115207","volume":"266","author":"RB Jain","year":"2020","unstructured":"Jain, R. B. Impact of the co-occurrence of obesity with diabetes, anemia, hypertension, and albuminuria on concentrations of selected perfluoroalkyl acids. Environ. Pollut. 266, 115207 (2020).","journal-title":"Environ. Pollut."},{"key":"57172_CR49","doi-asserted-by":"publisher","unstructured":"Lee, D.-H., Steffes, M. & JacobsJr, D. R. Positive associations of serum concentration of polychlorinated biphenyls or organochlorine pesticides with self-reported arthritis, especially rheumatoid type in women. Environ. Health Perspect. https:\/\/doi.org\/10.1289\/ehp.9887 (2007).","DOI":"10.1289\/ehp.9887"},{"key":"57172_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.scitotenv.2006.12.024","volume":"374","author":"PC Tsai","year":"2007","unstructured":"Tsai, P. C., Ko, Y. C., Huang, W., Liu, H. S. & Guo, Y. L. Increased liver and lupus mortalities in 24-year follow-up of the Taiwanese people highly exposed to polychlorinated biphenyls and dibenzofurans. Sci. Total Environ. 374, 216\u2013222 (2007).","journal-title":"Sci. Total Environ."},{"key":"57172_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.116222","volume":"231","author":"R-G Huang","year":"2023","unstructured":"Huang, R.-G. et al. Endocrine-disrupting chemicals and autoimmune diseases. Environ. Res. 231, 116222 (2023).","journal-title":"Environ. Res."},{"key":"57172_CR52","doi-asserted-by":"publisher","first-page":"e11281","DOI":"10.1371\/journal.pone.0011281","volume":"5","author":"A Rignell-Hydbom","year":"2010","unstructured":"Rignell-Hydbom, A. et al. A nested case-control study of intrauterine exposure to persistent organochlorine pollutants in relation to risk of type 1 diabetes. PLoS ONE 5, e11281 (2010).","journal-title":"PLoS ONE"},{"key":"57172_CR53","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.neuro.2006.11.002","volume":"28","author":"P Venkataraman","year":"2007","unstructured":"Venkataraman, P. PCB (Aroclor 1254) enhances oxidative damage in rat brain regions: protective role of ascorbic acid. Neurotoxicology 28, 490\u2013498 (2007).","journal-title":"Neurotoxicology"},{"key":"57172_CR54","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ijdevneu.2008.05.002","volume":"26","author":"P Venkataraman","year":"2008","unstructured":"Venkataraman, P. et al. Protective role of melatonin on PCB (Aroclor 1254) induced oxidative stress and changes in acetylcholine esterase and membrane bound ATPases in cerebellum, cerebral cortex and hippocampus of adult rat brain. Int. J. Dev. Neurosci. 26, 585\u2013591 (2008).","journal-title":"Int. J. Dev. Neurosci."},{"key":"57172_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78405-z","volume":"10","author":"T Idda","year":"2020","unstructured":"Idda, T. et al. Metabolic activation and toxicological evaluation of polychlorinated biphenyls in Drosophila melanogaster. Sci. Rep. 10, 1\u201312 (2020).","journal-title":"Sci. Rep."},{"key":"57172_CR56","doi-asserted-by":"crossref","unstructured":"Leong, J. Y., Blachman-Braun, R., Patel, A., Patel, P. & Ramasamy, R. 181 Association between polychlorinated biphenyl (PCB) 153 exposure and serum testosterone levels: analysis of the National Health and Nutrition Examination Survey. J. Sex. Med. 17, S60\u2013S61 (2020).","DOI":"10.1016\/j.jsxm.2019.11.127"},{"key":"57172_CR57","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1177\/1352458514527864","volume":"20","author":"R Bove","year":"2014","unstructured":"Bove, R. et al. Low testosterone is associated with disability in men with multiple sclerosis. Mult. Scler. 20, 1584\u20131592 (2014).","journal-title":"Mult. Scler."},{"key":"57172_CR58","doi-asserted-by":"publisher","unstructured":"Chitnis, T. The role of testosterone in MS risk and course. Mult. Scler. J. https:\/\/doi.org\/10.1177\/1352458517737395 (2018).","DOI":"10.1177\/1352458517737395"},{"key":"57172_CR59","doi-asserted-by":"publisher","first-page":"1415160","DOI":"10.3389\/fimmu.2024.1415160","volume":"15","author":"K Chen","year":"2024","unstructured":"Chen, K., Li, C., Zhao, B. & Shang, H. Albumin and multiple sclerosis: a prospective study from UK Biobank. Front. Immunol. 15, 1415160 (2024).","journal-title":"Front. Immunol."},{"key":"57172_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","volume":"7","author":"MB Sintzel","year":"2017","unstructured":"Sintzel, M. B., Rametta, M. & Reder, A. T. Vitamin D and multiple sclerosis: a comprehensive review. Neurol. Ther. 7, 59\u201385 (2017).","journal-title":"Neurol. Ther."},{"key":"57172_CR61","doi-asserted-by":"publisher","unstructured":"Giordano, A. et al. Vitamin D affects the risk of disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry https:\/\/doi.org\/10.1136\/jnnp-2024-334062 (2024).","DOI":"10.1136\/jnnp-2024-334062"},{"key":"57172_CR62","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3390\/nu15081945","volume":"15","author":"J Langlois","year":"2023","unstructured":"Langlois, J. & Denimal, D. Clinical and imaging outcomes after vitamin D supplementation in patients with multiple sclerosis: a systematic review. Nutrients 15, 1945 (2023).","journal-title":"Nutrients"},{"key":"57172_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijheh.2018.11.003","volume":"222","author":"TM Etzel","year":"2019","unstructured":"Etzel, T. M., Braun, J. M. & Buckley, J. P. Associations of serum perfluoroalkyl substance and vitamin D biomarker concentrations in NHANES, 2003-2010. Int. J. Hyg. Environ. Health 222, 262\u2013269 (2019).","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"57172_CR64","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1039\/D3EM00060E","volume":"25","author":"H Carlsson","year":"2023","unstructured":"Carlsson, H., Sreenivasan, A. P., Erngren, I., Larsson, A. & Kultima, K. Combining the targeted and untargeted screening of environmental contaminants reveals associations between PFAS exposure and vitamin D metabolism in human plasma. Environ. Sci. Process. Impacts 25, 1116\u20131130 (2023).","journal-title":"Environ. Sci. Process. Impacts"},{"key":"57172_CR65","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1352458512446169","volume":"19","author":"I Bostr\u00f6m","year":"2013","unstructured":"Bostr\u00f6m, I., Stawiarz, L. & Landtblom, A. M. Sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg). Mult. Scler. 19, 46\u201352 (2013).","journal-title":"Mult. Scler."},{"key":"57172_CR66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen, N. & S\u00f8rensen, P. S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 9, 520\u2013532 (2010).","journal-title":"Lancet Neurol."},{"key":"57172_CR67","doi-asserted-by":"publisher","unstructured":"Rommer, P. S. et al. Relapsing and progressive MS: the sex-specific perspective. Ther. Adv. Neurol. Disord. https:\/\/doi.org\/10.1177\/1756286420956495 (2020).","DOI":"10.1177\/1756286420956495"},{"key":"57172_CR68","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.clim.2013.03.005","volume":"149","author":"R Bove","year":"2013","unstructured":"Bove, R. & Chitnis, T. Sexual disparities in the incidence and course of MS. Clin. Immunol. 149, 201\u2013210 (2013).","journal-title":"Clin. Immunol."},{"key":"57172_CR69","doi-asserted-by":"publisher","first-page":"835162","DOI":"10.3389\/fneur.2022.835162","volume":"13","author":"J Leffler","year":"2022","unstructured":"Leffler, J., Trend, S., Gorman, S. & Hart, P. H. Sex-specific environmental impacts on initiation and progression of multiple sclerosis. Front. Neurol. 13, 835162 (2022).","journal-title":"Front. Neurol."},{"key":"57172_CR70","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40572-022-00332-0","volume":"9","author":"K Upson","year":"2022","unstructured":"Upson, K., Shearston, J. A. & Kioumourtzoglou, M.-A. An epidemiologic review of menstrual blood loss as an excretion route for per- and polyfluoroalkyl substances. Curr. Environ. Health Rep. 9, 29\u201337 (2022).","journal-title":"Curr. Environ. Health Rep."},{"key":"57172_CR71","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1539\/joh.46.141","volume":"46","author":"K Harada","year":"2004","unstructured":"Harada, K. et al. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years. J. Occup. Health 46, 141\u2013147 (2004).","journal-title":"J. Occup. Health"},{"key":"57172_CR72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00420-006-0136-1","volume":"80","author":"H Fromme","year":"2007","unstructured":"Fromme, H. et al. Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int. Arch. Occup. Environ. Health 80, 313\u2013319 (2007).","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"57172_CR73","doi-asserted-by":"publisher","first-page":"112677","DOI":"10.1016\/j.envres.2022.112677","volume":"209","author":"PM Lind","year":"2022","unstructured":"Lind, P. M. Serum levels of perfluoroalkyl substances (PFAS) and body composition \u2013 A cross-sectional study in a middle-aged population. Environ. Res. 209, 112677 (2022).","journal-title":"Environ. Res."},{"key":"57172_CR74","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.envint.2019.01.010","volume":"124","author":"LS Mamsen","year":"2019","unstructured":"Mamsen, L. S. et al. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies. Environ. Int. 124, 482\u2013492 (2019).","journal-title":"Environ. Int."},{"key":"57172_CR75","doi-asserted-by":"crossref","unstructured":"Hedstr\u00f6m, A. K., B\u00e4\u00e4rnhielm, M., Olsson, T. & Alfredsson, L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 73, 696\u2013701 (2009).","DOI":"10.1212\/WNL.0b013e3181b59c40"},{"key":"57172_CR76","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292\u2013302 (2011).","journal-title":"Ann. Neurol."},{"key":"57172_CR77","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u2018McDonald Criteria\u2019. Ann. Neurol. 58, 840\u2013846 (2005).","journal-title":"Ann. Neurol."},{"key":"57172_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ane.12425","volume":"132","author":"J Hillert","year":"2015","unstructured":"Hillert, J. & Stawiarz, L. The Swedish MS registry \u2013 clinical support tool and scientific resource. Acta Neurol. Scand. 132, 11\u201319 (2015).","journal-title":"Acta Neurol. Scand."},{"key":"57172_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12302-018-0134-4","volume":"30","author":"S Brendel","year":"2018","unstructured":"Brendel, S., Fetter, \u00c9., Staude, C., Vierke, L. & Biegel-Engler, A. Short-chain perfluoroalkyl acids: environmental concerns and a regulatory strategy under REACH. Environ. Sci. Eur. 30, 1\u201311 (2018).","journal-title":"Environ. Sci. Eur."},{"key":"57172_CR80","unstructured":"McDowall, J. G., Schaefer, T. H., Tisbury, M. & Whitehead, K. Perfluorohexane Sulfonate (PFHxS): Socio-Economic Impact, Exposure, and the Precautionary Principle (IPEN Expert Panel, 2019)."},{"key":"57172_CR81","unstructured":"R Core Team. R: a language and environment for statistical computing. https:\/\/www.R-project.org\/ (2023)."},{"key":"57172_CR82","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ene.15593","volume":"30","author":"C Pozzilli","year":"2023","unstructured":"Pozzilli, C. et al. Diagnosis and treatment of progressive multiple sclerosis: a position paper. Eur. J. Neurol. 30, 9 (2023).","journal-title":"Eur. J. Neurol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57172-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:44:51Z","timestamp":1740728691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57172-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57172"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57172-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.O. has received honoraria for lectures\/advisory boards from Biogen, Novartis, Merck, and Sanofi and unrestricted MS research grants from the same companies, academic grants from The Swedish Research Council, the Swedish Brain Foundation, Knut and Alice Wallenberg Foundation, and Margaretha af Ugglas Foundation. L.A. has received honoraria for lectures Biogen, Merck, and Teva, as well as academic grants from The Swedish Research Council, the Swedish Brain Foundation, the Swedish Council for Health, Working Life and Health, Region Stockholm, and the insurance company AFA. IK has received honoraria for lectures from Merck as well as research collaborative support from Neurogene INC for an unrelated project. The remaining authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2014"}}